Plasmalogens, phospholipase A2, and docosahexaenoic acid turnover in brain tissue

Journal of Molecular Neuroscience

Volumn 16, Issue 2-3, 2001, Pages 263-272

  Farooqui, A A ^a   Horrocks, L A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

And Alzheimer's disease; Arachidonic acid; Docosahexaenoic acid; Neural membranes; Peroxisome; Phospholipase A2; Plasmalogen

Indexed keywords

DOCOSAHEXAENOIC ACID; PHOSPHOLIPASE A2; PLASMALOGEN; ARACHIDONIC ACID DERIVATIVE; CELL SURFACE RECEPTOR; ISOENZYME; MEMBRANE LIPID; NERVE PROTEIN; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE A;

ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CATECHOLAMINE RELEASE; ENDOPLASMIC RETICULUM; ENZYME METABOLISM; GENE TARGETING; HUMAN; HUMAN TISSUE; HYDROLYSIS; LIPID METABOLISM; MACROPHAGE ACTIVATION; MYELINATION; NERVE MEMBRANE; PEROXISOME; ANIMAL; BRAIN; CALCIUM SIGNALING; CATTLE; CELL LINE; CELL MEMBRANE; DIET THERAPY; ENZYME SPECIFICITY; MACROPHAGE; METABOLISM; MOUSE; RAT; REVIEW; SIGNAL TRANSDUCTION; ZELLWEGER SYNDROME;

ANIMALS; ARACHIDONIC ACIDS; BRAIN; CALCIUM SIGNALING; CATTLE; CELL LINE; CELL MEMBRANE; DOCOSAHEXAENOIC ACIDS; ENDOPLASMIC RETICULUM; HUMANS; ISOENZYMES; MACROPHAGES; MEMBRANE LIPIDS; MICE; NERVE TISSUE PROTEINS; PEROXISOMES; PHOSPHATIDYLETHANOLAMINES; PHOSPHOLIPASES A; PLASMALOGENS; RATS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; ZELLWEGER SYNDROME;

EID: 0035317548     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:16:2-3:263     Document Type: Article

References (69)

1. Peroxisomal-microsomal communication in unsaturated fatty acid metabolism
2. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids
3. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder
4. 2
5. Deficiency of enzymes catalyzing the biosynthesis of glycerolether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes
6. Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins
7. 2, and signal transduction
8. Membrane phospholipid alterations in Alzheimer disease: Deficiency of ethanolamine plasmalogens
9. 2 in neurodegeneration
10. 2 and its role in brain tissue
11. 2: Localization, role, and involvement in neurological diseases
12. Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum
13. Plasmalogen status influences docosahexaenoic acid levels in a macrophage cell line: Insights using ether lipid-deficient variants
14. Membrane instability, plasmalogen content, and Alzheimer's disease
15. Peroxisomal disease
16. Mechanisms of docosahexaenoic acid accretion in the fetal brain
17. Developmental changes in rat brain membrane lipids and fatty acids: The preferential prenatal accumulation of docosahexaenoic acid
18. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease
19. The effect of docosahexaenoic acid on aggression in young adults: A placebo-controlled double-blind study
20. Severe plasmalogen deficiency in tissues of infants without peroxisomes (Zellweger syndrome)
21. Rhizomelic chondrodysplasia punctata: Another peroxisomal disorder
22. Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy
23. 2 from bovine brain cytosol
24. Content, composition, and metabolism of mammalian and avian lipids that contain ether groups
25. Plasmalogens and O-alkyl glycerophospholipids
26. Choline plasmalogens, glycerophospholipid methylation, and receptor-mediated activation of adenylate cyclase
27. Sources of brain arachidonic acid uptake and turnover in glycerophospholipids
28. Health benefits of docosahexaenoic acid (DHA)
29. Influence of docosahexaenoic acid on cerebral lipid peroxide level in aged rats with and without hypercholesterolemia
30. Antioxidative effects of docosahexaenoic acid in the cerebrum versus cerebellum and brainstem of aged hypercholesterolemic rats
31. Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse
32. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men
33. Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis
34. Biosynthesis and possible biological functions of plasmalogens
35. Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes?
36. Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: Comparison with bipolar patients and normal subjects
37. Plasmalogen phospholipids are involved in HDL-mediated cholesterol efflux: Insights from investigations with plasmalogen-deficient cells
38. Developmental maturation of hepatic n-3 polyunsaturated fatty acid metabolism: Supply of docosahexaenoic acid to retina and brain
39. Lipids of the developing human retina: I. Total fatty acids, plasmalogens, and fatty acid composition of ethanolamine and choline phosphoglycerides
40. Polyunsaturated fatty acid changes suggesting a new enzymatic defect in Zellweger syndrome
41. Severe deficiency of docosahexaenoic acid in peroxisomal disorders: A defect of delta 4 desaturation?
42. Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders
43. Why is docosahexaenoic acid essential for nervous system function?
44. Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6)
45. Local synthesis and targeting of essential fatty acids at the cellular interface between blood and brain: A role for cerebral endothelium and astrocytes in the accretion of CNS docosahexaenoic acid
46. Disappearance of plasmalogens from membranes of animal cells subjected to photosensitized oxidation
47. 2
48. The chronic administration of docosahexaenoic acid reduces the spatial cognitive deficit following transient forebrain ischemia in rats
49. 2 in the normal rat brain
50. The position of the double bonds in the monounsaturated alkl-enyl groups from the plasmalogens of human heart and brain
51. In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling
52. Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro
53. Polyunsaturated fatty acids in peroxisomal disorders: A hypothesis and a proposal for treatment
54. Docosahexaenoic acid: Membrane function and metabolism
55. Peroxisomal impairment in Niemann-Pick type C disease
56. Effect of docosahexaenoic acid on the generation of platelet-activating factor by eosinophilic leukemia cells, Eol-1
57. 2 during the hydrolysis of diacyl- and alkenylacylglycerophosphoethanolamine
58. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease
59. Distribution and fatty acid composition of phosphoglycerides in normal human brain
60. 2 appears to be mediated by the low affinity binding site of the TxA2/PGH2 receptor in U46619-stimuiated human platelets
61. Human dihydroxyacetonephosphate acyltransferase deficiency: A new peroxisomal disorder
62. Human alkyldihydroxyacetonephosphate synthase deficiency: A new peroxisomal disorder
63. Neural membrane phospholipids in Alzheimer disease
64. 2 from bovine brain
65. 2 from bovine brain
66. Essential fatty acids are mediators of brain biochemistry and cognitive functions
67. Pathophysiological effects of dietary essential fatty acid balance on neural systems
68. A possible role for plasmalogens in protecting animal cells against photosensitized killing
69. Mutants in a macrophage-like cell line are defective in plasmalogen biosynthesis, but contain functional peroxisomes